Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 10—October 2018
Letter

External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil

Cite This Article

To the Editor: Fischer et al. described an external quality assessment exercise for laboratories in Brazil that perform molecular testing for Zika virus and the development of an armored RNA control material (1). Armored RNAs are RNA transcripts synthesized by in vitro transcription; they are encapsulated in a bacteriophage protein coat and are nuclease resistant. In addition to the external quality assessment samples, laboratories were sent vials of the World Health Organization (WHO) International Standard (IS) for Zika virus, which was prepared by using heat-inactivated virus (2). Concentrations of WHO ISs are defined in IUs, in this case referring to the viral load, and, because of limitations on number of vials prepared in each batch, they are intended for calibrating secondary standards, including calibrators and run controls in IU facilitating comparison of assays (http://apps.who.int/medicinedocs/documents/s23325en/s23325en.pdf). Secondary standards, such as armored RNAs, traceable in IU (in accordance with ISO 17511:2003), are important complementary reagents to WHO ISs. However, the study by Fischer et al. was missing the calibration of the armored RNA in IU, which is essential for traceability.

Because of packaging limitations of the protein coat, armored RNAs contain only partial genome sequences, compared with live or inactivated virus preparations such as the WHO ISs, which contain full-length genomes. Consequently, armored RNAs are restricted to controlling only certain assays. However, it may be easier to import armored RNAs into countries where disease outbreaks are occurring because they are noninfectious and have not been derived from either viremic plasma or cell culture–derived virus that has undergone heat inactivation.

Inactivation protocols of viral stock materials must be validated on a case-by-case basis. Certain viruses, such as Zika virus, are heat labile (3), whereas viruses such as alphaviruses are much more heat resistant, although there is a wide variation in susceptibility to heat inactivation between different members of the genus (4,5). The availability of controls, such as armored RNAs, is essential to ensure consistent assay performance on a daily basis and maintain stocks of WHO IS samples for calibration.

Top

Sally A. BaylisComments to Author  and Johannes Blümel

Author affiliations: Paul-Ehrlich-Institut, Langen, Germany

Top

References

  1. Fischer  C, Pedroso  C, Mendrone  A Jr, Bispo de Filippis  AM, Vallinoto  ACR, Ribeiro  BM, et al. External quality assessment for Zika virus molecular diagnostic testing, Brazil. Emerg Infect Dis. 2018;24:88892. DOIPubMed
  2. Baylis  SA, Hanschmann  KO, Schnierle  BS, Trösemeier  JH, Blümel  J; Zika Virus Collaborative Study Group. Harmonization of nucleic acid testing for Zika virus: development of the 1st World Health Organization International Standard. Transfusion. 2017;57:74861. DOIPubMed
  3. Blümel  J, Musso  D, Teitz  S, Miyabayashi  T, Boller  K, Schnierle  BS, et al. Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products. Transfusion. 2017;57:7906. DOIPubMed
  4. Park  SL, Huang  YJ, Hsu  WW, Hettenbach  SM, Higgs  S, Vanlandingham  DL. Virus-specific thermostability and heat inactivation profiles of alphaviruses. J Virol Methods. 2016;234:1525. DOIPubMed
  5. Huang  YJ, Hsu  WW, Higgs  S, Vanlandingham  DL. Temperature tolerance and inactivation of chikungunya virus. Vector Borne Zoonotic Dis. 2015;15:6747. DOIPubMed

Top

Cite This Article

DOI: 10.3201/eid2410.180360

Original Publication Date: 8/28/2018

Related Links

Top

Table of Contents – Volume 24, Number 10—October 2018

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Sally A. Baylis, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, Langen, D-63225, Germany

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: September 16, 2018
Page updated: September 16, 2018
Page reviewed: September 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external